// App-Quantinova.ai

6628 : Low dose rate brachytherapy vs standard external beam radiotherapy vs stereotactic body radiotherapy for low risk prostate cancer: A cost-utility analysis.

Researchers

Presenter

  • Joelle Antoine Helou

Principal Investigators

  • Sofia Torres

  • Hima Bindu Musunuru

  • Patrick Cheung

  • Danny Vesprini

  • Hans T. Chung

  • Laura D'Alimonte

  • Ananth Ravi

  • Murray Krahn

  • Gerard Morton

  • Andrew Loblaw

Medical Centers

  • Sunnybrook Odette Cancer Centre, Toronto, ON, Canada

  • Odette Cancer Center, Sunnybrook Health Sciences Centre, Toronto, ON, Canada

  • University of Toronto, Toronto, ON, Canada

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Urology

Disease

  • Prostate cancer

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved